Breaking News Instant updates and real-time market news.

LYFT

Lyft

$59.38

-0.92 (-1.53%)

, GOOG

Alphabet

$1,174.87

-5.97 (-0.51%)

16:45
05/07/19
05/07
16:45
05/07/19
16:45

Lyft to offer rides from Waymo self-driving cars in Phoenix, WSJ reports

Lyft's (LYFT) ride-hailing app will soon begin offering rides from self-driving cars operated by Alphabet's (GOOG, GOOGL) Waymo in suburban Phoenix, Tim Higgins of Wall Street Journal reports. Waymo will initially deploy 10 vehicles with safety operators behind the wheel through the Lyft app in the next few months, Higgins added. Terms of the partnership weren't disclosed.Reference Link

LYFT

Lyft

$59.38

-0.92 (-1.53%)

GOOG

Alphabet

$1,174.87

-5.97 (-0.51%)

GOOGL

Alphabet Class A

$1,179.43

-5.68 (-0.48%)

  • 07

    May

  • 14

    May

  • 17

    May

  • 27

    Oct

LYFT Lyft
$59.38

-0.92 (-1.53%)

05/03/19
05/03/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Lyft (LYFT) initiated with an Underweight at Atlantic Equities. 2. Contura Energy (CTRA) initiated with a Buy at Seaport Global. 3. Uber (UBER) initiated with a Neutral at Atlantic Equities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/19
ATLE
05/03/19
INITIATION
Target $55
ATLE
Neutral
Atlantic starts Uber with Neutral rating despite preferring over Lyft
Atlantic Equities analyst James Cordwell initiated coverage of Uber (UBER) with a Neutral rating and $55 price target ahead of the company's initial public offering. The analyst this morning also initiated coverage of Lyft (LYFT) with an Underweight rating and $50 price target. Transportation-as-a-service addresses a large market opportunity, says the analyst, whose analysis shows that scale enables superior returns and a clearer path to profitability. Given the benefits of scale, Cordwell prefers Uber to Lyft, due to the company's "market-leading ridehailing position augmented by the fast-growing Eats business and freight brokerage opportunity." The analyst's year-end 2019 price target of $55 for Uber implies 0.9 times fiscal 2020 gross bookings, which he notes is similar to the historical average multiple of Amazon's (AMZN) e-commerce business.
05/03/19
ATLE
05/03/19
INITIATION
Target $50
ATLE
Underweight
Lyft initiated with an Underweight at Atlantic Equities
Atlantic Equities analyst James Cordwell initiated Lyft (LYFT) with an Underweight rating and $50 price target. In a research note to investors, Cordwell, who also initiated Uber (UBER) with a Neutral rating, says he prefers Uber over Lyft, as U.S. share losses and deteriorating unit economics leave him unable to be constructive on Lyft currently, especially given ongoing capital inflows into the sector will likely ensure competition remains intense.
05/03/19
COWN
05/03/19
NO CHANGE
Target $77
COWN
Outperform
Cowen sees strong results coming from Lyft in first public report
Cowen analyst John Blackledge said he expects "strong results" from Lyft in its first earnings report since coming public, which is due on next Tuesday, May 7. He forecasts active riders to have increased 40% year-over-year to 19.7M and sees revenue at $745M, which would be up 88% year-over-year compared to the 94% growth rate from the company's fourth quarter. Blackledge forecasts an adjusted EBITDA loss of $243.4M, which compares to a consensus estimate of a loss of $282.4M. He maintains an Outperform rating and $77 price target on Lyft shares.
GOOG Alphabet
$1,174.87

-5.97 (-0.51%)

04/30/19
04/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Stifel with analyst Scott Devitt saying Alphabet revenue growth in last night's Q1 results dropped below 20% for the first time since Q2 of 2015. 2. Bank of America (BAC) downgraded to Neutral from Overweight at Atlantic Equities. 3. Trade Desk (TTD) downgraded to Market Perform from Outperform at JMP Securities with analyst Ronald Josey saying he believes shares are currently fairly valued given the company's growth and opportunities in mobile and Connected TV. 4. ADP (ADP) downgraded to Market Perform from Outperform at Bernstein while Paychex (PAYX) was downgraded to Underperform from Market Perform. 5. Trex Company (TREX) downgraded to Neutral from Buy at B. Riley FBR with analyst Alex Rygiel citing near-term profit margin pressures. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/30/19
OPCO
04/30/19
NO CHANGE
Target $1342
OPCO
Outperform
Alphabet price target lowered to $1,342 from $1,435 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for Alphabet to $1,342 from $1,435 following quarterly results, while reiterating an Outperform rating on the shares. Despite weaker ad results and lower core margins year over year, the analyst notes that Alphabet is a "cash cow," dominating search, and compounding its core business, with numerous new initiatives at just 11-times 2020 EBITDA and 21-times free cash flow.
04/30/19
MSCO
04/30/19
NO CHANGE
Target $1425
MSCO
Overweight
Alphabet price target lowered to $1,425 from $1,500 at Morgan Stanley
Morgan Stanley analyst Brian Nowak noted that this quarter was the first in the last 17 in which Alphabet's Websites revenue grew less than 20% ex-foreign exchange. While the company pointed to "the timing of product changes in ads" as a factor that drove the deceleration, it did not provide any clarity on what the changes were, whether the impact will be linear, or whether there are more such changes to come, noted Nowak, who sees the need for better transparency as key to long-term valuation at Alphabet. Following the quarterly report, he lowered his FY19 and FY20 EBITDA estimates by1% and 3%, respectively, and cut his price target on Alphabet shares to $1,425 from $1,500. Nowak keeps an Overweight rating on the stock.
04/30/19
DBAB
04/30/19
NO CHANGE
Target $1300
DBAB
Buy
Alphabet price target lowered to $1,300 from $1,385 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley lowered his price target for Alphabet to $1,300 from $1,385 saying maturation fears are rising after he company's revenue growth slowed in Q1. Alphabet reported "weak" results with Google Sites growth excluding currency ticking down by 4 percentage points, cost growth ahead of revenue growth, a "vocal commitment" to invest with less signal on discipline than last quarter's comments, and a continued focus on the low-margin hardware space which is struggling with sales declines in the flagship product, Walmsley tells investors in a post-earnings research note. He also thinks management did a poor job explaining the slowdown. The analyst, despite lowering his estimates, keeps a Buy rating on Alphabet. He thinks the stock's valuation is attractive on a long-term basis.
GOOGL Alphabet Class A
$1,179.43

-5.68 (-0.48%)

04/30/19
FBCO
04/30/19
NO CHANGE
Target $1400
FBCO
Outperform
Credit Suisse remains a buyer of Alphabet following quarterly results
Credit Suisse analyst Stephen Ju says that despite incremental signs of free cash flow beginning to grow again, as well as ongoing moderation of core segment operating margin compression, he expects FX-neutral revenue growth deceleration to 19% year over year to weigh on Alphabet shares. As the benefits from the investments Google continues to incur toward generating new streams of revenue are nontransparent, Ju suspects that from a tactical perspective the bear argument that it needs to spend to maintain growth in its current businesses will get louder. That said, the analyst notes that while the Street has implicitly modeled the costs around the company's various longer duration products, revenue is not yet reflected, and hence he remains a buyer of the shares on that optionality. He reiterates an Outperform rating and $1,400 price target on the shares.
04/30/19
BMOC
04/30/19
NO CHANGE
Target $1150
BMOC
Market Perform
Alphabet price target lowered to $1,150 from $1,200 at BMO Capital
BMO Capital analyst Daniel Salmon lowered his price target on Alphabet (GOOGL) to $1,150 after its Q1 revenue missed expectations, ending the run of 10 of 11 quarters of top-line beats. The analyst says the company offered little color on slowing revenue outside of stating that the "timing of product changes in ads" impacted growth and warns that consensus earnings for the year have added risk. Salmon also keeps his Market Perform rating on Alphabet, stating that the Street may underestimate margin erosion from its negative revenue mix-shift while pointing to Amazon's (AMZN) rise of advertising business as a competitive threat.
05/01/19
DZBN
05/01/19
DOWNGRADE
DZBN
Hold
Alphabet downgraded to Hold from Buy at DZ Bank

TODAY'S FREE FLY STORIES

CTVA

Corteva

$25.20

0.23 (0.92%)

20:49
06/16/19
06/16
20:49
06/16/19
20:49
Upgrade
Corteva rating change  »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$125.30

0.45 (0.36%)

, SNE

Sony

$51.42

1.735 (3.49%)

19:15
06/16/19
06/16
19:15
06/16/19
19:15
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

UTX

United Technologies

$125.30

0.45 (0.36%)

SNE

Sony

$51.42

1.735 (3.49%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GS

Goldman Sachs

$191.71

0.24 (0.13%)

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

BA

Boeing

$347.19

-1.54 (-0.44%)

RTN

Raytheon

$177.38

0.195 (0.11%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 23

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

GM

General Motors

$35.66

-0.36 (-1.00%)

18:49
06/16/19
06/16
18:49
06/16/19
18:49
Periodicals
GM won't deploy self-driving fleet until safer than human driver, Axios reports »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

T

AT&T

$32.36

0.06 (0.19%)

, CMCSA

Comcast

$42.31

0.62 (1.49%)

17:58
06/16/19
06/16
17:58
06/16/19
17:58
On The Fly
Box Office Battle: 'Men in Black: International' wins weekend with just $28.5M »

Sony’s (SNE) "Men in…

T

AT&T

$32.36

0.06 (0.19%)

CMCSA

Comcast

$42.31

0.62 (1.49%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.42

1.735 (3.49%)

LGF.A

Lionsgate

$12.22

-0.85 (-6.50%)

DIS

Disney

$141.64

-0.09 (-0.06%)

VIAB

Viacom

$29.38

-0.28 (-0.94%)

VIA

Viacom

$34.61

0.14 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

GS

Goldman Sachs

$191.71

0.24 (0.13%)

17:43
06/16/19
06/16
17:43
06/16/19
17:43
Periodicals
Goldman Sachs combining private-investing units, WSJ reports »

Goldman Sachs is pulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

17:38
06/16/19
06/16
17:38
06/16/19
17:38
Periodicals
Deutsche Bank to set up EUR50B bad bank, Financial Times reports »

Deutsche Bank is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$87.10

(0.00%)

16:35
06/16/19
06/16
16:35
06/16/19
16:35
Periodicals
Tires blow on United jet during Newark airport landing, Reuters reports »

Tires on a United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$87.83

-0.48 (-0.54%)

16:33
06/16/19
06/16
16:33
06/16/19
16:33
Periodicals
Target registers back online after outage blamed on tech issue, Reuters says »

Target said its payment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.18

-0.54 (-1.16%)

16:30
06/16/19
06/16
16:30
06/16/19
16:30
Hot Stocks
Intel announces program for Israeli startups targeting tech inflections »

Intel announced a program…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:27
06/16/19
06/16
16:27
06/16/19
16:27
Periodicals
Boeing says will take time to rebuild customer confidence, Reuters reports »

The head of Boeing said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

GS

Goldman Sachs

$191.71

0.24 (0.13%)

16:19
06/16/19
06/16
16:19
06/16/19
16:19
Periodicals
Goldman Sachs skeptical of 'insurance' rate cuts from Fed, Reuters says »

Goldman Sachs economists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:16
06/16/19
06/16
16:16
06/16/19
16:16
Periodicals
Trials nearing for Boeing 737 Max fix, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

ESLT

Elbit Systems

$154.55

0.55 (0.36%)

13:41
06/16/19
06/16
13:41
06/16/19
13:41
Hot Stocks
Elbit Systems awarded $50M contract »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$176.09

-0.74 (-0.42%)

13:40
06/16/19
06/16
13:40
06/16/19
13:40
Hot Stocks
Amgen announces BLINCYTO five-year overall survival data »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SILK

Silk Road Medical

$44.80

-0.95 (-2.08%)

13:35
06/16/19
06/16
13:35
06/16/19
13:35
Hot Stocks
Silk Road Medical announces final results for ROADSTER-2 study »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 26

    Aug

EDIT

Editas Medicine

$21.72

-0.78 (-3.47%)

13:30
06/16/19
06/16
13:30
06/16/19
13:30
Hot Stocks
Editas presents pre-clinical data in Sickle Cell Disease, Beta-Thalassemia »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.90

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28
Hot Stocks
Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

APLS

Apellis

$21.22

-0.14 (-0.66%)

13:23
06/16/19
06/16
13:23
06/16/19
13:23
Hot Stocks
Apellis presents data from ongoing Phase 2 PLAUDIT study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$90.65

-0.35 (-0.38%)

12:59
06/16/19
06/16
12:59
06/16/19
12:59
Hot Stocks
Blueprint Medicines presents updated EXPLORER trial data for Avapritinib »

Blueprint Medicines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

INCY

Incyte

$77.76

1.385 (1.81%)

12:52
06/16/19
06/16
12:52
06/16/19
12:52
Hot Stocks
Incyte announced results from Phase 2 study of Ruxolitinib cream in vitiligo »

Incyte announces 24-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

, INCY

Incyte

$77.76

1.385 (1.81%)

04:55
06/16/19
06/16
04:55
06/16/19
04:55
Conference/Events
European Hematology Association to hold a conference »

24th EHA Congress 2019…

ABBV

AbbVie

$78.69

-0.27 (-0.34%)

INCY

Incyte

$77.76

1.385 (1.81%)

ARQL

ArQule

$8.17

1.88 (29.89%)

AMGN

Amgen

$176.09

-0.74 (-0.42%)

ALXN

Alexion

$117.94

0.65 (0.55%)

AGIO

Agios Pharmaceuticals

$47.97

-1.78 (-3.58%)

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

BLUE

Bluebird Bio

$117.57

-6.33 (-5.11%)

BMY

Bristol-Myers

$47.57

0.25 (0.53%)

CELG

Celgene

$96.49

0.07 (0.07%)

NVS

Novartis

$89.52

-0.07 (-0.08%)

NSTG

NanoString

$25.96

0.45 (1.76%)

KPTI

Karyopharm

$5.71

-0.04 (-0.70%)

JAZZ

Jazz Pharmaceuticals

$130.43

0.28 (0.22%)

GSK

GlaxoSmithKline

$40.12

0.015 (0.04%)

GILD

Gilead

$66.38

-0.62 (-0.93%)

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

PFE

Pfizer

$42.75

0.24 (0.56%)

PTLA

Portola Pharmaceuticals

$25.78

-0.31 (-1.19%)

QGEN

Qiagen

$39.52

-0.07 (-0.18%)

RHHBY

Roche

$0.00

(0.00%)

RIGL

Rigel Pharmaceuticals

$2.06

-0.06 (-2.83%)

SNY

Sanofi

$42.46

-0.225 (-0.53%)

SGEN

Seattle Genetics

$68.67

-0.33 (-0.48%)

STML

Stemline

$14.20

0.12 (0.85%)

VSTM

Verastem

$1.39

0.125 (9.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 18

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 21

    Jun

  • 23

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 06

    Jul

  • 25

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 28

    Aug

  • 29

    Aug

  • 02

    Sep

  • 03

    Sep

  • 16

    Sep

  • 04

    Nov

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

, GRUB

GrubHub

$70.15

-2.76 (-3.79%)

13:28
06/15/19
06/15
13:28
06/15/19
13:28
Periodicals
Amazon exit gives GrubHub stock boost, Barron's says »

Amazon (AMZN) is…

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.